Breaking News Instant updates and real-time market news.

ATRS

Antares Pharma

$3.30 /

+0.08 (+2.48%)

07:01
05/05/20
05/05
07:01
05/05/20
07:01

Antares Pharma reports Q1 EPS (1c), consensus 0c

Reports Q1 revenue $33.1M, consensus $30.68M. "Our first quarter revenue performance underscores the strength of our commercial and operations organizations at a time when COVID-19 impacted the global economy and our business during the last month of the quarter. XYOSTED recorded another quarter of double-digit prescription growth over the prior quarter driven once again by a significant increase in both patients and prescribers. We continue to believe XYOSTED represents the most effective option for treating low testosterone in hypogonadal men, especially in an at-home treatment setting. On the partnered product front where we provide devices, Teva achieved a thirteen percent increase in generic epipen prescriptions in the first quarter of 2020 versus the fourth quarter of 2019 and importantly achieved a seven percent increase in market share over the same period," said Robert F. Apple, President and Chief Executive Officer of the Company. "With respect to the COVID-19 pandemic, we continue to monitor this global health crisis as it relates to our ongoing operations, and we have taken various steps to potentially reduce the impact of the pandemic on our business. Antares is focused on helping to ensure patients continue to have access to our medicines while protecting the health and well-being of both our employees and our customers. At this time, while we have seen a softening in new patient starts for our products, it is difficult to predict the full financial impact on our business given the current economic slowdown and uncertainty surrounding the duration of the pandemic. However, we believe the Company is in a strong financial position, allowing us to navigate through these unprecedented times while continuing to execute on our key strategic objectives supporting long-term growth."

  • 05

    May

ATRS Antares Pharma
$3.30 /

+0.08 (+2.48%)

11/06/19 H.C. Wainwright
Antares reported revenue upside across portfolio, says H.C. Wainwright

TODAY'S FREE FLY STORIES

Hot Stocks
AstraZeneca reports 'steps towards broad and equitable access' to COVID vaccine » 11:16
06/04/20
06/04
11:16
06/04/20
11:16
AZN

AstraZeneca

$54.45 /

-0.55 (-1.00%)

AstraZeneca announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

Technical Analysis
NYSE market internals summary » 11:16
06/04/20
06/04
11:16
06/04/20
11:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

General news
4-Week Bill Auction to be released at 11:30  11:15
06/04/20
06/04
11:15
06/04/20
11:15
 
General news
8-Week Bill Auction to be released at 11:30  11:15
06/04/20
06/04
11:15
06/04/20
11:15
 
General news
6-Month Bill Announcement Offering Amount data reported » 11:14
06/04/20
06/04
11:14
06/04/20
11:14

6-Month Bill Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
30-Yr Bond Announcement CUSIP Number data reported » 11:14
06/04/20
06/04
11:14
06/04/20
11:14

30-Yr Bond Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
30-Yr Bond Announcement Offering Amount data reported » 11:14
06/04/20
06/04
11:14
06/04/20
11:14

30-Yr Bond Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
3-Month Bill Announcement Offering Amount data reported » 11:14
06/04/20
06/04
11:14
06/04/20
11:14

3-Month Bill Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
3-Yr Note Announcement CUSIP Number data reported » 11:14
06/04/20
06/04
11:14
06/04/20
11:14

3-Yr Note Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
3-Yr Note Announcement Offering Amount data reported » 11:14
06/04/20
06/04
11:14
06/04/20
11:14

3-Yr Note Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
10-Yr Note Announcement CUSIP Number data reported » 11:14
06/04/20
06/04
11:14
06/04/20
11:14

10-Yr Note Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
10-Yr Note Announcement Offering Amount data reported » 11:14
06/04/20
06/04
11:14
06/04/20
11:14

10-Yr Note Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

On The Fly
Inovio, Novavax analysts undeterred by White House vaccine snub » 11:12
06/04/20
06/04
11:12
06/04/20
11:12
INO

Inovio

$12.52 /

+0.07 (+0.56%)

, NVAX

Novavax

$44.38 /

+0.12 (+0.27%)

, MRNA

Moderna

$59.95 /

+0.065 (+0.11%)

, AZN

AstraZeneca

$54.45 /

-0.55 (-1.00%)

, JNJ

Johnson & Johnson

$146.14 /

-2.54 (-1.71%)

, MRK

Merck

$81.26 /

-0.81 (-0.99%)

, PFE

Pfizer

$35.97 /

-0.185 (-0.51%)

Shares of Inovio…

Open Full Text

ShowHide Related Items >><<
INO Inovio
$12.52 /

+0.07 (+0.56%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

PFE Pfizer
$35.97 /

-0.185 (-0.51%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

08:00 Today Cantor Fitzgerald
Inovio, Novavax COVID vaccines should not be disregarded, says Cantor
06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
NVAX Novavax
$44.38 /

+0.12 (+0.27%)

08:00 Today Cantor Fitzgerald
Inovio, Novavax COVID vaccines should not be disregarded, says Cantor
06/03/20 B. Riley FBR
Novavax selloff on 'Warp Speed' report unwarranted, says B. Riley FBR
05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
MRNA Moderna
$59.95 /

+0.065 (+0.11%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$81.26 /

-0.81 (-0.99%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
PFE Pfizer
$35.97 /

-0.185 (-0.51%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
INO Inovio
$12.52 /

+0.07 (+0.56%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

PFE Pfizer
$35.97 /

-0.185 (-0.51%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

PFE Pfizer
$35.97 /

-0.185 (-0.51%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

PFE Pfizer
$35.97 /

-0.185 (-0.51%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

PFE Pfizer
$35.97 /

-0.185 (-0.51%)

Syndicate
ZoomInfo indicated to open at $40, IPO priced at $21  11:10
06/04/20
06/04
11:10
06/04/20
11:10
ZI

ZoomInfo

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 04
    Jun
Options
Penn National call volume above normal and directionally bullish » 11:05
06/04/20
06/04
11:05
06/04/20
11:05
PENN

Penn National

$35.52 /

+2.79 (+8.52%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PENN Penn National
$35.52 /

+2.79 (+8.52%)

PENN Penn National
$35.52 /

+2.79 (+8.52%)

05/27/20 Morgan Stanley
Penn National price target raised to $32 from $21 at Morgan Stanley
05/20/20 JPMorgan
Penn National price target raised to $28 from $21 at JPMorgan
05/08/20 Deutsche Bank
Penn National price target lowered to $12 from $32 at Deutsche Bank
04/27/20 Nomura Instinet
Nomura sees 'attractive upside' in Boyd and Penn National as casinos reopen
PENN Penn National
$35.52 /

+2.79 (+8.52%)

PENN Penn National
$35.52 /

+2.79 (+8.52%)

PENN Penn National
$35.52 /

+2.79 (+8.52%)

PENN Penn National
$35.52 /

+2.79 (+8.52%)

General news
Today's U.S. reports » 11:05
06/04/20
06/04
11:05
06/04/20
11:05

Today's U.S. reports…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Canada Goose reported Q4 adjusted EPS C(12c) vs. C 9c a year ago » 11:03
06/04/20
06/04
11:03
06/04/20
11:03
GOOS

Canada Goose

$25.00 /

-0.4 (-1.57%)

Yesterday, Canada Goose…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOOS Canada Goose
$25.00 /

-0.4 (-1.57%)

GOOS Canada Goose
$25.00 /

-0.4 (-1.57%)

10:49 Today Credit Suisse
Canada Goose price target lowered to C$40 from C$43 at Credit Suisse
09:30 Today RBC Capital
Canada Goose price target raised to C$47 from C$35 at RBC Capital
08:16 Today Susquehanna
Canada Goose price target raised to C$42 from C$35 at Susquehanna
06/02/20 RBC Capital
Canada Goose wholesale disruption largely priced in, says RBC Capital
GOOS Canada Goose
$25.00 /

-0.4 (-1.57%)

GOOS Canada Goose
$25.00 /

-0.4 (-1.57%)

GOOS Canada Goose
$25.00 /

-0.4 (-1.57%)

GOOS Canada Goose
$25.00 /

-0.4 (-1.57%)

Hot Stocks
Nikola chair says 'no doubt' will need to raise more money 'down the road' » 11:01
06/04/20
06/04
11:01
06/04/20
11:01
NKLA

Nikola

$36.80 /

+2.82 (+8.30%)

Milton says "a good…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKLA Nikola
$36.80 /

+2.82 (+8.30%)

NKLA Nikola
$36.80 /

+2.82 (+8.30%)

Syndicate
ZoomInfo indicated to open at $42, IPO priced at $21  10:59
06/04/20
06/04
10:59
06/04/20
10:59
ZI

ZoomInfo

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 04
    Jun
Hot Stocks
Nikola executive chair sees revenue to come 'about middle of next year' » 10:55
06/04/20
06/04
10:55
06/04/20
10:55
NKLA

Nikola, currently trades as VTIQ

$37.10 /

+3.12 (+9.18%)

Nikola Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKLA Nikola, currently trades as VTIQ
$37.10 /

+3.12 (+9.18%)

NKLA Nikola, currently trades as VTIQ
$37.10 /

+3.12 (+9.18%)

General news
Equity Action: stocks are rebounding » 10:55
06/04/20
06/04
10:55
06/04/20
10:55

Equity Action: stocks are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Options
Royal Dutch Shell put volume heavy and directionally bearish » 10:55
06/04/20
06/04
10:55
06/04/20
10:55

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Standard Bank to host conference call » 10:55
06/04/20
06/04
10:55
06/04/20
10:55
SGBLY

Standard Bank

$0.00 /

+ (+0.00%)

Management holds an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGBLY Standard Bank
$0.00 /

+ (+0.00%)

03/13/20 HSBC
Standard Bank upgraded to Buy from Hold at HSBC
Hot Stocks
Fastenal reports May sales up 4.4% to $493.21M » 10:51
06/04/20
06/04
10:51
06/04/20
10:51
FAST

Fastenal

$42.39 /

+0.34 (+0.81%)

Fastenal reports May net…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FAST Fastenal
$42.39 /

+0.34 (+0.81%)

FAST Fastenal
$42.39 /

+0.34 (+0.81%)

04/15/20 Argus
Fastenal weakness offers buying opportunity, says Argus
04/15/20 Baird
Looming recession favors Fastenal outperformance, says Baird
04/14/20 Raymond James
Fastenal dividend secure, onsite business remains challenged, says Raymond James
04/14/20 William Blair
Fastenal April sales down only 10%-11% 'biggest surprise,' says William Blair
FAST Fastenal
$42.39 /

+0.34 (+0.81%)

FAST Fastenal
$42.39 /

+0.34 (+0.81%)

FAST Fastenal
$42.39 /

+0.34 (+0.81%)

Hot Stocks
SeaWorld says Busch Gardens, Adventure Island in Tampa to open June 11 » 10:51
06/04/20
06/04
10:51
06/04/20
10:51
SEAS

SeaWorld

$19.10 /

+0.54 (+2.91%)

SeaWorld Entertainment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SEAS SeaWorld
$19.10 /

+0.54 (+2.91%)

SEAS SeaWorld
$19.10 /

+0.54 (+2.91%)

10:06 Today
Fly Intel: Top five analyst upgrades
06:37 Today Citi
Citi upgrades SeaWorld to Buy on 'compelling' risk/reward
05:59 Today Citi
SeaWorld upgraded to Buy from Neutral at Citi
05/28/20
Fly Intel: Top five analyst initiations
SEAS SeaWorld
$19.10 /

+0.54 (+2.91%)

SEAS SeaWorld
$19.10 /

+0.54 (+2.91%)

SEAS SeaWorld
$19.10 /

+0.54 (+2.91%)

SEAS SeaWorld
$19.10 /

+0.54 (+2.91%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.